INHIBITION BY GABA, BACLOFEN AND GABAPENTIN OF DOPAMINE RELEASE FROM RABBIT CAUDATE-NUCLEUS - ARE THERE COMMON OR DIFFERENT SITES OF ACTION

被引:94
作者
REIMANN, W
机构
关键词
D O I
10.1016/0014-2999(83)90425-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:341 / 344
页数:4
相关论文
共 9 条
[1]  
BARTOSZYK GD, 1983, N-S ARCH PHARMACOL, V322, pR94
[2]  
BOWERY NG, 1979, BRIT J PHARMACOL, V67, pP444
[3]   CHARACTERISTICS OF GABAB RECEPTOR-BINDING SITES ON RAT WHOLE BRAIN SYNAPTIC-MEMBRANES [J].
BOWERY, NG ;
HILL, DR ;
HUDSON, AL .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (01) :191-206
[4]   (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR [J].
BOWERY, NG ;
HILL, DR ;
HUDSON, AL ;
DOBLE, A ;
MIDDLEMISS, DN ;
SHAW, J ;
TURNBULL, M .
NATURE, 1980, 283 (5742) :92-94
[5]   GABAA AND GABAB RECEPTOR-MEDIATED EFFECTS IN GUINEA-PIG ILEUM [J].
GIOTTI, A ;
LUZZI, S ;
SPAGNESI, S ;
ZILLETTI, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (03) :469-478
[6]  
ONG J, 1983, European Journal of Pharmacology, V86, P9
[7]  
REIMANN W, 1982, J NEUROCHEM, V39, P961, DOI 10.1111/j.1471-4159.1982.tb11483.x
[8]   EFFECT OF DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS ON RELEASE OF DOPAMINE IN RABBIT CAUDATE-NUCLEUS INVITRO [J].
STARKE, K ;
REIMANN, W ;
ZUMSTEIN, A ;
HERTTING, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1978, 305 (01) :27-36
[9]   PATHWAYS OF DOPAMINE METABOLISM IN THE RABBIT CAUDATE-NUCLEUS INVITRO [J].
ZUMSTEIN, A ;
KARDUCK, W ;
STARKE, K .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 316 (03) :205-217